Clinical Trial Update: A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic Hepatitis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety, pharmacokinetics, and pharmacodynamics of DUR-928 in patients with alcoholic hepatitis has completed and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• DUR-928

Snippet

Sponsor: Durect | Conditions: Alcoholic Hepatitis | Phase 2 | Status: COMPLETED | Results posted: 2022-12-14